Lentiviral vectors have emerged as indispensable tools in gene therapy, offering the ability to integrate therapeutic genes into both dividing and non-dividing cells. Their unique capacity to achieve ...

CD19-targeting UB-VV11 became the first in vivo CAR-T cell therapy to be cleared for human testing by the FDA last year, and ...

Lentiviral vectors effectively deliver the gene that encodes coagulation factor IX (FIX) to the liver in dogs with naturally occurring hemophilia B (factor IX deficiency), researchers report in an ...

Verismo Therapeutics, a clinical-stage CAR T company developing a novel KIR-CAR platform technology, today announced the ...

FA is an inherited syndrome that impairs the body's chromosomal repair systems, causing the bone marrow to lose its ability ...

The vector purification market offers significant growth potential due to increasing demand for viral vectors in gene and ...

Lentiviral vector improves anemia and iron metabolism in new model for X-linked sideroblastic anemia Jan. 22, 2025 ...

ProBio recently opened a gene therapy hub in a 128,000-square-foot facility in Mercer County, bringing more than 100 high-skilled jobs to the region. The flagship Cell and Gene Therapy Center of ...